Medical education · Dr. Mariana Sato

14 Apr 2026 · Phone · Dr. Mariana Sato, Uniklinik Köln · MSL James Whitfield · Vantrexa

ReviewedVeeva CRMENG-0045MI request

Capture insight from this engagement

Location: Uniklinik Köln
Therapeutic area: Oncology
Country: Germany
Stakeholder tier: Tier 2
Strategic objective: Not linked
Initiative: Not linked
MSL: JWJames WhitfieldSenior MSL, Oncology (US East)
Product: Vantrexa (vantrelimab)

Topics discussed

Comparator checkpoint monotherapy
Infusion-reaction management
Sequencing after progression

Scientific content used

PD-L1 testing pathway infographic

Questions raised

No questions recorded.

Notes

Medical education with thoracic medical oncologist at Uniklinik Köln. Discussed comparator checkpoint monotherapy, infusion-reaction management, sequencing after progression.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

No follow-ups recorded.

Quality ratings

1–5, rated at review

Scientific relevance: 4
Strategic relevance: 5
Depth of exchange: 3
Actionability: 5

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0045

Audit history (0)

All create, update and approval events for this record

No audit events in sample data